We are live on
!
Find out more
AIIC
AJU IB Investment Company Portfolio holdings
AUM
$30.5M
1-Year Est. Return
128.96%
This Fund
S&P 500
This Quarter
Est. Return
-4.42%
1 Year Est. Return
+128.96%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$22.8M
AUM Growth
-$92.3M
(-80%)
Cap. Flow
-$95.3M
Cap. Flow
% of AUM
-418.11%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACLX
Arcellx
ACLX
|
+$65.7M |
| 2 |
Kymera Therapeutics
KYMR
|
+$29.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
LGM
OGC
AC
PL
WVP
VL
CPM
SP
AJU IB Investment Company's Q4 2025 Portfolio in Review
As of Q4 2025, AJU IB Investment Company held 7 positions worth $22.8M, down 80% from $115M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
AJU IB Investment Company withdrew a net $95.3M in Q4 2025, reducing 2 holdings. Its largest reduction was Arcellx, cutting an estimated $65.7M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- AJU IB Investment Company's biggest Q4 2025 reduction was Arcellx, cutting an estimated $65.7M.
- AJU IB Investment Company's ten largest holdings make up 100% of its $22.8M portfolio in Q4 2025.
- AJU IB Investment Company opened 0 new positions and closed 0 in Q4 2025.
- AJU IB Investment Company's portfolio value fell 80% quarter-over-quarter to $22.8M.
Based on AJU IB Investment Company's 13F filing for Q4 2025, filed 10 Feb 2026.